Patients with PJS predominantly develop hamartomatous polyps that are generally benign, indicating LOF mutations in LKB1 predispose these patients to cancer but that additional mutations in other genes are required for the development of a malignant phenotype. The gene discussed is STK11; the disease is cancer.